GX-D1

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameGX-D1
Drug Alias Nameprogrammed death 1/hybrid Fc antibody fragment fusion protein (Genexine)PD1-hyFc fusion protein (Genexine)GX-D1
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody fragmentBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionProgrammed death-ligand 1 modulators
TargetsProgrammed death-ligand 1
Therapy Area/IndicationsCommunicable Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesGannex Pharma Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGannex Pharma Co Ltd
Active IndicationsN/A
Inactive IndicationsCommunicable Diseases

Other Information

ATC CodeN/A
Related LinksN/A